KLK3 and prostate carcinoma: Although prostate cancer incidence rates decreased for several years in the mid 1990s, more recent data show that incidence rates are again increasing [5,19,20] and survey results from the Centers for Disease Control's Behavioural Risk Factor Surveillance System (BRFSS) show that a high proportion of American men continue to undergo PSA testing [20].